PT  - JOURNAL ARTICLE
AU  - Xiu Nie
AU  - Liujia Qian
AU  - Rui Sun
AU  - Bo Huang
AU  - Xiaochuan Dong
AU  - Qi Xiao
AU  - Qiushi Zhang
AU  - Tian Lu
AU  - Liang Yue
AU  - Shuo Chen
AU  - Xiang Li
AU  - Yaoting Sun
AU  - Lu Li
AU  - Luang Xu
AU  - Yan Li
AU  - Ming Yang
AU  - Zhangzhi Xue
AU  - Shuang Liang
AU  - Xuan Ding
AU  - Chunhui Yuan
AU  - Li Peng
AU  - Wei Liu
AU  - Xiao Yi
AU  - Mengge Lyu
AU  - Guixiang Xiao
AU  - Xia Xu
AU  - Weigang Ge
AU  - Jiale He
AU  - Jun Fan
AU  - Junhua Wu
AU  - Meng Luo
AU  - Xiaona Chang
AU  - Huaxiong Pan
AU  - Xue Cai
AU  - Junjie Zhou
AU  - Jing Yu
AU  - Huanhuan Gao
AU  - Mingxing Xie
AU  - Sihua Wang
AU  - Guan Ruan
AU  - Hao Chen
AU  - Hua Su
AU  - Heng Mei
AU  - Danju Luo
AU  - Dashi Zhao
AU  - Fei Xu
AU  - Yan Li
AU  - Yi Zhu
AU  - Jiahong Xia
AU  - Yu Hu
AU  - Tiannan Guo
TI  - Multi-organ Proteomic Landscape of COVID-19 Autopsies
AID  - 10.1101/2020.08.16.20176065
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.16.20176065
4099  - http://medrxiv.org/content/early/2020/08/19/2020.08.16.20176065.1.short
4100  - http://medrxiv.org/content/early/2020/08/19/2020.08.16.20176065.1.full
AB  - The molecular pathology of multi-organ injuries in COVID-19 patients remains unclear, preventing effective therapeutics development. Here, we report an in-depth multi-organ proteomic landscape of COVID-19 patient autopsy samples. By integrative analysis of proteomes of seven organs, namely lung, spleen, liver, heart, kidney, thyroid and testis, we characterized 11,394 proteins, in which 5336 were perturbed in COVID-19 patients compared to controls. Our data showed that CTSL, rather than ACE2, was significantly upregulated in the lung from COVID-19 patients. Dysregulation of protein translation, glucose metabolism, fatty acid metabolism was detected in multiple organs. Our data suggested upon SARS-CoV-2 infection, hyperinflammation might be triggered which in turn induces damage of gas exchange barrier in the lung, leading to hypoxia, angiogenesis, coagulation and fibrosis in the lung, kidney, spleen, liver, heart and thyroid. Evidence for testicular injuries included reduced Leydig cells, suppressed cholesterol biosynthesis and sperm mobility. In summary, this study depicts the multi-organ proteomic landscape of COVID-19 autopsies, and uncovered dysregulated proteins and biological processes, offering novel therapeutic clues.HIGHLIGHTSCharacterization of 5336 regulated proteins out of 11,394 quantified proteins in the lung, spleen, liver, kidney, heart, thyroid and testis autopsies from 19 patients died from COVID-19.CTSL, rather than ACE2, was significantly upregulated in the lung from COVID-19 patients.Evidence for suppression of glucose metabolism in the spleen, liver and kidney; suppression of fatty acid metabolism in the kidney; enhanced fatty acid metabolism in the lung, spleen, liver, heart and thyroid from COVID-19 patients; enhanced protein translation initiation in the lung, liver, renal medulla and thyroid.Tentative model for multi-organ injuries in patients died from COVID-19: SARS-CoV-2 infection triggers hyperinflammatory which in turn induces damage of gas exchange barrier in the lung, leading to hypoxia, angiogenesis, coagulation and fibrosis in the lung, kidney, spleen, liver, heart, kidney and thyroid.Testicular injuries in COVID-19 patients included reduced Leydig cells, suppressed cholesterol biosynthesis and sperm mobility.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by grants from Tencent Foundation (2020), National Natural Science Foundation of China (81972492, 21904107, 81672086, 81773022), Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars (LR19C050001), the Key Special Project of Ministry of Science and Technology, China (No.2020YFC0845700), the Fundamental Research Funds for the Central Universities (No.2020kfyXGYJ101), and Hangzhou Agriculture and Society Advancement Program (20190101A04).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Medical Ethics Committee of Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology (No.2020-0043-1) and Medical Ethical Committee of Westlake University (No.20200329GTN001).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe proteomics data is deposited in ProteomeXchange Consortium (https://www.iprox.org/). Project ID: IPX0002393000. The data will be publicly available upon publication in a journal.